Annual Cash & Cash Equivalents
$6.61B$492.60M+8.05%
Summary
- Current Value
- As of today, VRTX annual cash & cash equivalents is $6.61B, up +8.05% on
- Historical Performance
- VRTX annual cash & cash equivalents is down -38.71% over the past 3 years, down -0.73% over the past 5 years
- All-Time High Comparison
- VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on
- 3-Year Low Comparison
- VRTX annual cash & cash equivalents is +8.05% above its 3-year low of $6.12B reached on
- Sector Comparison
- VRTX annual cash & cash equivalents is higher than 98.33% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $6.61B | +8.1% | -38.7% | -0.7% | +541.0% | |
| Quarterly Cash & Cash Equivalents | $7.86B | +23.0% | -30.0% | +17.1% | +1097.5% | |
| Price | $528.19 | +35.5% | +53.2% | +171.2% | +1066.2% | |
| Annual Current Assets | $11.20B | +16.7% | -15.4% | +37.7% | +959.7% | |
| Annual Total Liabilities | $7.48B | +11.9% | +76.4% | +143.9% | +512.1% | |
| Annual Working Capital | $7.34B | +21.7% | -30.1% | +17.3% | +1160.6% | |
| Annual Net Income | $3.95B | +838.1% | +19.0% | +45.8% | +623.9% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.22B | -41.1% | |
| 5Y | $11.22B | -41.1% | |
| All | $11.22B | -41.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.12B | +8.1% | |
| 5Y | $6.12B | +8.1% | |
| All | $4.40M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of VRTX?
- As of today, VRTX annual cash & cash equivalents is $6.61B
- What is 1-year change in VRTX annual cash & cash equivalents?
- VRTX annual cash & cash equivalents is up +8.05% year-over-year
- What is 3-year change in VRTX annual cash & cash equivalents?
- VRTX annual cash & cash equivalents is down -38.71% over the past 3 years
- How far is VRTX annual cash & cash equivalents from its all-time high?
- VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on December 31, 2023
- How does VRTX annual cash & cash equivalents rank versus sector peers?
- VRTX annual cash & cash equivalents is higher than 98.33% of companies in Healthcare sector
- When is VRTX next annual earnings release?
- As of today, the next annual earnings release for VRTX has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$7.86B$604.30M+8.33%
Summary
- Current Value
- As of today, VRTX quarterly cash & cash equivalents is $7.86B, up +8.33% on
- Historical Performance
- VRTX quarterly cash & cash equivalents is up +23.00% year-over-year, down -30.04% over the past 3 years
- All-Time High Comparison
- VRTX quarterly cash & cash equivalents is currently -34.12% below its historical high of $11.93B set on
- 3-Year Low Comparison
- VRTX quarterly cash & cash equivalents is +35.67% above its 3-year low of $5.80B reached on
- Sector Comparison
- VRTX quarterly cash & cash equivalents is higher than 98.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $7.86B | +8.3% | +23.0% | -30.0% | +17.1% | |
| Annual Cash & Cash Equivalents | $6.61B | – | +8.1% | -38.7% | -0.7% | |
| Price | $528.19 | +21.0% | +35.5% | +53.2% | +171.2% | |
| Quarterly Current Assets | $12.54B | +6.9% | +20.3% | -9.6% | +48.3% | |
| Quarterly Total Liabilities | $7.18B | +0.7% | +4.6% | +47.1% | +137.2% | |
| Quarterly Working Capital | $8.61B | +9.6% | +36.8% | -18.2% | +30.0% | |
| Quarterly Net Income | $1.10B | +6.6% | +6.5% | +20.1% | +1543.4% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.86B | at high | |
| 3Y | $11.93B | -34.1% | |
| 5Y | $11.93B | -34.1% | |
| All | $11.93B | -34.1% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.30B | +24.9% | |
| 3Y | $5.80B | +35.7% | |
| 5Y | $5.80B | +35.7% | |
| All | $2.30M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of VRTX?
- As of today, VRTX quarterly cash & cash equivalents is $7.86B
- What is VRTX quarterly cash & cash equivalents most recent change?
- VRTX quarterly cash & cash equivalents was up +8.33% on June 30, 2026
- What is 1-year change in VRTX quarterly cash & cash equivalents?
- VRTX quarterly cash & cash equivalents is up +23.00% year-over-year
- How far is VRTX quarterly cash & cash equivalents from its all-time high?
- VRTX quarterly cash & cash equivalents is currently -34.12% below its historical high of $11.93B set on September 30, 2023
- How does VRTX quarterly cash & cash equivalents rank versus sector peers?
- VRTX quarterly cash & cash equivalents is higher than 98.93% of companies in Healthcare sector
- When is VRTX next earnings release?
- The next earnings release for VRTX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx